Loading clinical trials...

UNKNOWNNA

Effect of Physiotherapy Protocol in Treatment of Depression: Longitudinal Study

NCT05786677•Cairo University

Summary

The purpose of his study is to investigate the effect of physiotherapy protocol in management of depression in patients with fibromyalgia and in patients with psychogenic depression.

Detailed Description

This study will investigate the effect of physiotherapy protocol in management of depression in patients with fibromyalgia and in patients with psychogenic depression.

Eligibility

Age

20 - 60 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Fibromyalgia patients will be included if they meet the diagnosis of FM according to the American College Rheumatology (ACR), diagnosed with depression and referred by a physician.
•2. Patients diagnosed with mild and moderate forms of major depression.
•3. Their ages range from 20- 60 years old.
•4. Patients willing and able to participate in a physiotherapy program and capable of doing physical exercise on their own.

Exclusion Criteria

•1. severe spinal injuries
•2. severe musculoskeletal abnormalities
•3. inflammatory rheumatic diseases
•4. respiratory or cardiac pathologies
•5. Any vestibular, visual or neurological dysfunction affecting balance.
•6. History of suicidal attempts
•7. Severe depression
•8. Suffering from severe somatic or psychiatric disorders.

Locations (1)

Outpatient clinic faculty of physica therapy cairo university

Dokki, Egypt

Key Dates

Start Date

April 1, 2023

Primary Completion Date

June 15, 2023

Completion Date

August 15, 2023

Last Updated

March 27, 2023

Enrollment

ESTIMATED participants

Conditions

FibromyalgiaDepression

Interventions

Physiotherapy protocol

OTHER

Selective serotonin reuptake inhibitors (SSRI)

DRUG

Contacts

Mahitab Momen

CONTACT

010226960790 bobapt@hotmail.com

Mahitab Momen

CONTACT

bobapt@hotmail.com

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600

ParentsChildren With Disabilities+2 more

View study

RECRUITINGPHASE3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397

Major Depressive Disorder (MDD)Depression in Adults+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 27, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effect of Physiotherapy Protocol in Treatment of Depression: Longitudinal Study

Inclusion Criteria

Exclusion Criteria

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Readiness and Progress in Emotion Regulation Therapy

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures